Latest News & Features
Americas
Medical device company, Globus Medical, has filed a lawsuit against competitor Life Spine, alleging infringement of seven different patents related to spinal tech implant technology. 14 October 2021
article
The issue of how to define an antibody for patent protection purposes has been fiercely debated worldwide. Should it be defined by function, or its amino acid sequence? Takanori Abe will discuss the first antibody patent infringement lawsuit in Japan, Baxalta v Genentech & Chugai Pharmaceuticals, and the second, Amgen v Sanofi. Abe’s insights on the case are informed by his previous experience representing Baxalta in Japan. 14 October 2021
Generics
Bayer Healthcare and drug importer Meda Pharmaceuticals have sued generic manufacturer Apotex, alleging that its planned generic nasal spray infringes on Bayer’s Astepro patents. 12 October 2021
Generics
Teva Pharmaceuticals has once again petitioned the US Court of Appeals for the Federal Circuit to reconsider its decision in a dispute over generic drug labelling which held that the drugmaker infringed GlaxoSmithKline’s Coreg heart drug. 12 October 2021
Big Pharma
The English High Court has found that a challenged claim of Bayer's targeted cancer drug sorafenib is invalid due to obviousness, in a win for Israeli pharmaceutical company Teva Pharmaceuticals. 11 October 2021
Medtech
The US Court of Appeals for the Federal Circuit has held that claims of a patent covering an artificial heart valve were erroneously held to be unpatentable by the US Patent Trial and Appeal Board, in a blow to a medical device company owned by Abbott Laboratories. 7 October 2021
Americas
The unpredictable nature of the US legal landscape has arguably kept IP practitioners on tenterhooks over the past decade. 7 October 2021
Biotechnology
Medical device company SurgiSil has persuaded the US Court of Appeals for the Federal Circuit that its application for a design patent covering a lip filler was erroneously rejected by the US Patent and Trademark Office. 6 October 2021
Generics
A New Jersey court has invalidated a Sun Pharmaceuticals patent related to its anti-inflammatory eye drops BromSite in an infringement suit against generic drug manufacturer Lupin Pharmaceuticals. 5 October 2021
Americas
The US Court of Appeals for the Eleventh Circuit has found that the US Food and Drug Administration violated the exclusivity of a patent covering a drug for a rare autoimmune disorder, by approving the same treatment specifically for children. 4 October 2021